| B78 | Characterizing the impact of COVID-19 among female sex workers living with HIV in Durban, South Africa | E-poster | COVID-19 morbidity and mortality in PLWH |
| B78 | Seroprevalence and risk factors of SARS-CoV-2 infection in people living with HIV | E-poster | COVID-19 morbidity and mortality in PLWH |
| B78 | Mortality COVID-19 in people living with HIV in a private insurance carrier in Colombia | E-poster | COVID-19 morbidity and mortality in PLWH |
| B15 | Incidence trends of five common sexually transmitted infections excluding HIV from 1990 to 2019 at the global, regional, and national levels: results from the Global Burden of Disease Study 2019 | E-poster | Syphilis and other sexually transmitted infections |
| B35 | 24 week randomised study of switch to DTG/RPV in subjects with HIV RNA <50c/ml and archived K103N | E-poster | Regimen simplification and switch studies |
| B46 | Lower HIV reservoir size in individuals who maintain higher CD4+ T cells counts prior to antiretroviral therapy initiation: the Strategic Timing of Antiretroviral Treatment (START) HIV reservoir study | E-poster | Cure interventions |
| B52 | Update on neural tube defects with antiretoviral exposure in the Tsepamo study, Botswana | E-poster | Sex-specific issues of ART efficacy, adverse reactions and complications |
| B59 | Pharmacokinetics and safety of dispersible and immediate release FDC abacavir/dolutegravir/lamivudine in children with HIV weighing '¥14 kg: preliminary results from IMPAACT 2019 | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
| B59 | Pharmacokinetics, safety and acceptability of a single dose of abacavir/lamivudine/lopinavir/ritonavir (4-in-1) fixed-dose granule formulation in neonates: PETITE study | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
| B61 | Virological failures and genotypic resistance in children and adolescents randomised to dolutegravir-based ART vs. standard-of-care in the ODYSSEY trial | E-poster | Clinical trials in paediatric and adolescent populations |